Karuna Therapeutics to Announce Third Quarter 2023 Financial Results and Provide General Business Update on Thursday, November 2, 2023
19 10월 2023 - 7:30PM
Business Wire
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical
company driven to discover, develop, and deliver transformative
medicines for people living with psychiatric and neurological
conditions, today announced that it will host a live conference
call and webcast on Thursday, November 2, 2023 at 8:00 a.m. ET to
review third quarter 2023 financial results and provide a general
business update.
A live webcast of the presentation will be available on the
Investor Relations page of Karuna’s website at
investors.karunatx.com. A replay of the webcast will also be
archived for up to 30 days on Karuna’s website following the
completion of the event.
About Karuna Therapeutics Karuna Therapeutics is a
biopharmaceutical company driven to discover, develop, and deliver
transformative medicines for people living with psychiatric and
neurological conditions. At Karuna, we understand there is a need
for differentiated and more effective treatments that can help
patients navigate the challenges presented by serious mental
illness. Utilizing our extensive knowledge of neuroscience, we are
harnessing the untapped potential of the brain in pursuit of novel
pathways to develop medicines that make meaningful differences in
peoples’ lives. For more information, please visit
www.karunatx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231019342719/en/
Investors: Alexis Smith +1 (617) 352-9917
asmith@karunatx.com
Media: Julie Ciardiello +1 (917) 647-0159
julie.ciardiello@karunatx.com
Karuna Therapeutics (NASDAQ:KRTX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Karuna Therapeutics (NASDAQ:KRTX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024